Kathleen Wells advises public and private companies in, venture capital firms, and investment banks on a full spectrum of corporate governance, securities law, and transactional matters, with a particular focus on the life sciences and technology sectors.

Drawing on extensive experience across multiple industries, Kathleen guides clients of all sizes — from startups to mature public companies — and their boards, investors, and investment banks on a range of matters, including:

  • Capital markets transactions, including initial public offerings (IPOs) and follow-on offerings
  • Mergers and acquisitions
  • Venture capital financings
  • Corporate governance matters
  • Public company disclosure issues
  • Federal and state securities law compliance
  • Equity incentives and employment matters
  • Company formation and startup matters

A recognized leader at the firm, Kathleen was Co-Chair of the Silicon Valley Corporate Department from 2011-2019 and has served on the Mentoring, Recruiting, Women Enriching Business (WEB), and several industry group committees.

Kathleen’s experience includes representing:

Capital Markets

  • Airbnb in its IPO
  • Alkami in its IPO
  • Amplitude in its direct listing
  • Annexon in its IPO, PIPE, and at-the-market offering
  • Blackhawk Network Holdings in its IPO and spin off from Safeway
  • The Cheesecake Factory in its convertible note offering and concurrent follow-on offering
  • Ceribell in its IPO
  • Codexis in its follow-on offerings
  • Corcept Therapeutics in its follow-on offering
  • Corvus Pharmaceuticals in its IPO and follow-on offering
  • Eargo in its IPO
  • e.l.f. Beauty in its IPO and secondary offering 
  • Eventbrite in its convertible note offering
  • lntermune in its follow-on offering
  • Mellanox Technologies in its IPO
  • OpenTable in its IPO and follow-on offering
  • Prothena in its follow-on offerings
  • Raptor Pharmaceutical in its at-the-market offering and follow-on offering
  • Renovis in its IPO
  • Wag! Group Co. in its follow-on offering
  • Zosano Pharma in its follow-on and at-the-market offering s

Mergers & Acquisitions

  • Aduro in its merger with Chinook
  • Bella Pictures in its sale to CPI Corp.
  • CV Therapeutics in its sale to Gilead Sciences
  • Delivery Agent in its acquisition of Billion Dollar Babes
  • Mellanox Technologies in its acquisition of Voltaire
  • OpenTable in its sale to Priceline and acquisitions including GuestBridge, Just Chalo, RezBook, Table Maestro, toptable.com, and Treat Technologies 
  • Raptor Pharmaceutical in its sale to Horizon Pharma pc
  • ReCAPTCHA in its sale to Google
  • Relievant MedSystems in its sale to Boston Scientific Corporation
  • The Cheesecake Factory in its acquisition of Fox Restaurant Concepts 
  • Twitch in its sale to Amazon
  • ViVu in its sale to Polycom

Venture Capital Financings

(Companies and Investors)

  • Alkami
  • Annexon
  • ARCH
  • Babylist
  • Bella Pictures
  • Bessemer Venture Partners 
  • Cambrios
  • Canaan Partners
  • Cascade Asset Management Company
  • Ceribell
  • Claret Medical
  • Corvus Pharmaceuticals
  • CuraSen Therapeutics
  • Delivery Agent
  • Eargo
  • Freeborders
  • Fresco Kitchen
  • Frontier Medicines 
  • Gate Bioscience
  • Intuity Medical
  • Joby Aviation
  • Joyful Habits
  • Kymeta 
  • MediaTek
  • Mentor Graphics 
  • Mercator MedSystems
  • Myoscience
  • Nexus India Capital Omada Health
  • ooyala
  • Postmates 
  • Proterra
  • Relievant MedSystems
  • RIPPL Care
  • Salma Health
  • Sana Biotechnology
  • Siluria Technologies
  • Silver Lake 
  • Stir Money
  • Tenvie Therapeutics
  • U.S. Venture Partners

Bar Qualification

  • California

Education

  • JD, Stanford Law School, 2001
  • BA, University of Arizona, 1996